COLUMBUS, Ohio--(BUSINESS WIRE)--Forge Biologics (“Forge”), a leading ... The Rejuva platform is in preclinical development and has not yet been evaluated by regulatory agencies for ...

Despite securing a much-needed $5 million lifeline from an equity offering this week, HCW Biologics is continuing to warn ...

HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and ...

AGC Biologics has partnered with Quell Therapeutics to support the development of multiple Treg cell therapy drug candidates.

MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the“Company” or“HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...

Makers of organoids and cell models cheered the decision and said it will bolster the development of precision medicines, ...

BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced the appointment of Alan Korman, Ph.D., as Chief Scientific Officer. Dr. Korman brings ...

For PLG's clients, the collaboration opens access to Recipharm's manufacturing infrastructure, including integrated and ...

DELRAY BEACH, FL / ACCESS Newswire / April 23, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company") is developing intracellularly-delivered neuromodulators that naturally reduce neuronal ...